Category Specific RSS

News

Paradigm’s study could give options to those with this rare incurable disease

Clinical stage biopharmaceutical company Paradigm Biopharmaceuticals (ASX: PAR) has been given the green light to go ahead with a Phase…

5 years ago

Move over x-ray: 4D Medical’s respiratory scanning tech could be the new standard in imaging

Invented in 1895 and becoming the standard in the early 1900s, the x-ray has long been the backbone of many…

5 years ago

DC Two launches new vertical offering eco-friendly Bitcoin mining data centres

With the price of Bitcoin appearing to have found its newest support level amid the price boom which sent BTC…

5 years ago

The ASX small cap stock set for a boost from Amazon Prime Day

If you haven’t seen the ads that have been peppering Australian television and media over the past week, Amazon Prime…

5 years ago

Family lawsuits booming as AF Legal finalises NSW expansion

With such an increase in time spent at home over the past year as a result of the pandemic, it…

5 years ago

Spray-on skin revenue exceeds initial forecasts

The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter…

5 years ago

Domestic tourism meets sharing economy as Camplify aims to list with $58m IPO

While the future on when Aussies can holiday overseas remains unclear, one company is seizing the opportunity that has now…

5 years ago

Cash Converters so much more than pawn brokers as non-bank lending thrives

At a time when Buy Now Pay Later companies have disrupted the Australian credit economy, Cash Converters (ASX: CCV) is…

5 years ago

Goop might have been right…

The keto diet is proving to be more than just another “It” diet touted by Goop with interesting research showing…

5 years ago

Pharmaxis eyes cancer treatment trials in US as dosage study advances

A new treatment for the deadly bone marrow cancer myelofibrosis is one step closer to a FDA application with clinical…

5 years ago